Related Experiment Videos

Phorbol esters regulate preprogastrin-releasing peptide messenger RNA in small cell lung cancer cells

M Draoui1, T W Moody, Z Fathi

  • 1Department of Biochemistry and Molecular Biology, George Washington University Medical Center, Washington, D.C. 20037.

Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research
|September 1, 1993
PubMed

Insights

Phorbol ester (PMA) stimulates gastrin-releasing peptide (GRP) mRNA transcription in small cell lung cancer (SCLC) cells, mediated by protein kinase C. This finding offers insights into SCLC gene regulation.

Area of Science:

  • Molecular Biology
  • Oncology
  • Cell Biology

Background:

  • Gastrin-releasing peptide (GRP) is a key peptide in small cell lung cancer (SCLC).
  • Understanding GRP gene regulation is crucial for SCLC therapeutic strategies.

Purpose of the Study:

  • To investigate the effect of 4 beta-phorbol 12-myristate 13 alpha-acetate (PMA) on preprogastrin-releasing peptide (GRP) mRNA expression in SCLC cells.
  • To elucidate the underlying molecular mechanisms, including the role of protein kinase C (PKC).

Main Methods:

  • Northern analysis to quantify preproGRP mRNA levels.
  • Nuclear run-on assays to assess transcriptional activity.
  • Protein kinase C inhibition and down-regulation studies.
  • Cell growth assays in vitro.

Main Results:

  • PMA significantly increased preproGRP mRNA expression in a dose- and time-dependent manner.
  • PMA enhanced preproGRP gene transcription by approximately 3-fold, without affecting beta-actin or glyceraldehyde 3-phosphate dehydrogenase transcription.
  • The effect of PMA on preproGRP mRNA was dependent on active protein kinase C.
  • PMA stimulated SCLC cell growth, while the PKC inhibitor H7 reduced it.

Conclusions:

  • Phorbol ester (PMA) induces the transcription of GRP mRNA in SCLC cells.
  • Protein kinase C activation is essential for PMA-induced GRP gene expression in SCLC.
  • These findings highlight a potential therapeutic target for modulating GRP in SCLC.

Related Concept Videos